Charles River Laboratories Acquires HemaCare Corporation

January 8, 2020

Charles River Laboratories Acquires HemaCare Corporation

Contract research organization, Charles River Laboratories has acquired HemaCare Corporation. The acquisition was completed at $380 million; HemaCare is a leading producer of human-derived cellular products for the cell therapy market. Yourway’s global, integrated depot network supports the transport of highly sensitive drugs and clinical trial material across borders.

Back to Index

Media

Upcoming Events

Global Clinical Supplies Group (GCSG)

October 14-16, 2025
Hungary, Budapest

Schedule a Meeting

Clinical Outsourcing Group (COG)

October 21-22, 2025
Burlingame, California

Schedule a Meeting

Media

Articles

Case study: Coordinating a complex intercontinental shipment on a short timeline

Open chat

Hello! How can I help you?